Prevalence of Risk Factors for Ischaemic Stroke and Their Treatment Among a Cohort of Stroke Patients in Dublin

Overview

Journal Ir J Med Sci

Specialty General Medicine

Date 2001 May 31

PMID 11381792

Citations 1

Authors

R McDonnell

C W Fan

Z Johnson

M Crowe

Affiliations

Soon will be listed here.

Abstract

Background: The majority of strokes are due to ischaemia. Risk factors include atrial fibrillation, hypertension and smoking. The incidence can be reduced by addressing these risk factors. This study examines the prevalence of risk factors and their treatment in a cohort of patients with ischaemic stroke registered on a Dublin stroke database.

Methods: Patients admitted to any of three acute hospitals with a diagnosis of stroke during a one-year period in 1997/98 were registered on a database using the European Stroke Database format. Data relating to common risk factors were analysed.

Results: There were 238 ischaemic stroke cases registered. The most frequent medical risk factors were: hypertension (45%), atrial fibrillation (27.3%), and previous disabling or non-disabling stroke (33.2%). There was an increasing trend with advancing age for atrial fibrillation (p < 0.001). Some 23% (54/233) were current smokers. A significantly higher proportion of patients with no medical risk factors were smokers or consumed excessive alcohol compared with those who had medical risk factors.

Conclusion: Medical risk factors for stroke were common among stroke patients and not optimally treated, particularly with regard to atrial fibrillation and previous stroke. Smoking was a major behavioural risk factor among younger patients and much health gain could be achieved in this group through primary prevention strategies.

Citing Articles

Trends in one-year mortality for stroke in a tertiary academic center in Saudi Arabia: a 5-year retrospective analysis.

Almekhlafi M Ann Saudi Med. 2016; 36(3):197-202.

PMID: 27236391 PMC: 6074538. DOI: 10.5144/0256-4947.2016.197.

References

Sacco R, Elkind M, Boden-Albala B, Lin I, Kargman D, Hauser W . The protective effect of moderate alcohol consumption on ischemic stroke. JAMA. 1999; 281(1):53-60. DOI: 10.1001/jama.281.1.53. View

Mohr J, Caplan L, Melski J, GOLDSTEIN R, Duncan G, Kistler J . The Harvard Cooperative Stroke Registry: a prospective registry. Neurology. 1978; 28(8):754-62. DOI: 10.1212/wnl.28.8.754. View

. Stroke--1989. Recommendations on stroke prevention, diagnosis, and therapy. Report of the WHO Task Force on Stroke and other Cerebrovascular Disorders. Stroke. 1989; 20(10):1407-31. DOI: 10.1161/01.str.20.10.1407. View

Tuomilehto J, Rastenyte D, Jousilahti P, Sarti C, Vartiainen E . Diabetes mellitus as a risk factor for death from stroke. Prospective study of the middle-aged Finnish population. Stroke. 1996; 27(2):210-5. DOI: 10.1161/01.str.27.2.210. View

. A randomized trial of aspirin and sulfinpyrazone in threatened stroke. N Engl J Med. 1978; 299(2):53-9. DOI: 10.1056/NEJM197807132990201. View

Murray C, Lopez A . Mortality by cause for eight regions of the world: Global Burden of Disease Study. Lancet. 1997; 349(9061):1269-76. DOI: 10.1016/S0140-6736(96)07493-4. View

Gorelick P, Sacco R, Smith D, Alberts M, Rader D, Ross J . Prevention of a first stroke: a review of guidelines and a multidisciplinary consensus statement from the National Stroke Association. JAMA. 1999; 281(12):1112-20. DOI: 10.1001/jama.281.12.1112. View

. Collaborative overview of randomised trials of antiplatelet therapy--I: Prevention of death, myocardial infarction, and stroke by prolonged antiplatelet therapy in various categories of patients. Antiplatelet Trialists' Collaboration. BMJ. 1994; 308(6921):81-106. PMC: 2539220. View

Macmahon S, Peto R, Cutler J, Collins R, Sorlie P, Neaton J . Blood pressure, stroke, and coronary heart disease. Part 1, Prolonged differences in blood pressure: prospective observational studies corrected for the regression dilution bias. Lancet. 1990; 335(8692):765-74. DOI: 10.1016/0140-6736(90)90878-9. View

10.

Wannamethee S, Shaper A . Patterns of alcohol intake and risk of stroke in middle-aged British men. Stroke. 1996; 27(6):1033-9. DOI: 10.1161/01.str.27.6.1033. View

11.

Du X, Sourbutts J, Cruickshank K, Summers A, Roberts N, Walton E . A community based stroke register in a high risk area for stroke in north west England. J Epidemiol Community Health. 1998; 51(5):472-8. PMC: 1060530. DOI: 10.1136/jech.51.5.472. View

12.

Wolf P, Abbott R, Kannel W . Atrial fibrillation: a major contributor to stroke in the elderly. The Framingham Study. Arch Intern Med. 1987; 147(9):1561-4. View

13.

Kalra L, Perez I, Melbourn A . Stroke risk management: changes in mainstream practice. Stroke. 1998; 29(1):53-7. DOI: 10.1161/01.str.29.1.53. View

14.

. Stroke Prevention in Atrial Fibrillation Study. Final results. Circulation. 1991; 84(2):527-39. DOI: 10.1161/01.cir.84.2.527. View

15.

Hayes C, Johnson Z, Hynes M . Utilisation of hospital beds by the elderly--a cohort study of admissions to a teaching hospital. Ir Med J. 1995; 88(4):124-6. View

16.

Sudlow M, Thomson R, Thwaites B, Rodgers H, Kenny R . Prevalence of atrial fibrillation and eligibility for anticoagulants in the community. Lancet. 1998; 352(9135):1167-71. DOI: 10.1016/S0140-6736(98)01401-9. View

17.

Whittle J, Wickenheiser L, Venditti L . Is warfarin underused in the treatment of elderly persons with atrial fibrillation?. Arch Intern Med. 1997; 157(4):441-5. View

18.

Munschauer F, Priore R, Hens M, Castilone A . Thromboembolism prophylaxis in chronic atrial fibrillation. Practice patterns in community and tertiary-care hospitals. Stroke. 1997; 28(1):72-6. DOI: 10.1161/01.str.28.1.72. View

19.

Radic A, Finn A, Haran R, Dean G . Incidence of strokes in Dublin. Ir Med J. 1977; 70(19):591-6. View

20.

Du X, Cruickshank K, McNamee R, Saraee M, Sourbutts J, Summers A . Case-control study of stroke and the quality of hypertension control in north west England. BMJ. 1997; 314(7076):272-6. PMC: 2125717. DOI: 10.1136/bmj.314.7076.272. View